Author Archives: Marisa Wexler MS

Gene Therapy for CLN2 Shows Good Safety in Small Clinical Trial

An investigational gene therapy for late infantile (CLN2) Batten disease showed a good safety profile in a small clinical trial. The gene therapy also slowed the progression of the disease, though not to the extent of current standard-of-care treatment. Researchers are now working on more effective ways to deliver…